From January 1, 2022 to March 23, 2022, the company has repurchased 240,000 shares, representing 0.84% for ¥255.53 million. With this, the company has completed the repurchase of 300,000 shares, representing 1.06% for ¥316.48 million under the buyback announced on July 12, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,302 JPY | -1.67% | +8.74% | +29.04% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.04% | 428M | |
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B |
- Stock Market
- Equities
- 4886 Stock
- News ASKA Pharmaceutical Holdings Co.,Ltd.
- Tranche Update on ASKA Pharmaceutical Holdings Co.,Ltd.'s Equity Buyback Plan announced on July 12, 2021.